| Serial Number | 88886693 |
| Word Mark | ELEVIDYS |
| Filing Date | Friday, April 24, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 25, 2023 |
| Registration Number | 7037471 |
| Registration Date | Tuesday, April 25, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 14, 2020 |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapies for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 5, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, March 11, 2023 |
| First Use In Commerce Date | Saturday, March 11, 2023 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Tuesday, April 25, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, April 25, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, March 23, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Wednesday, March 22, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Monday, March 20, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Tuesday, March 14, 2023 | USE AMENDMENT FILED |
| Tuesday, March 14, 2023 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, March 7, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 6, 2023 | SOU EXTENSION 5 GRANTED |
| Friday, February 17, 2023 | SOU EXTENSION 5 FILED |
| Friday, March 3, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, February 17, 2023 | TEAS EXTENSION RECEIVED |
| Friday, August 26, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 24, 2022 | SOU EXTENSION 4 GRANTED |
| Wednesday, August 24, 2022 | SOU EXTENSION 4 FILED |
| Wednesday, August 24, 2022 | TEAS EXTENSION RECEIVED |
| Saturday, February 19, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 17, 2022 | SOU EXTENSION 3 GRANTED |
| Thursday, February 17, 2022 | SOU EXTENSION 3 FILED |
| Thursday, February 17, 2022 | TEAS EXTENSION RECEIVED |
| Saturday, August 28, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 26, 2021 | SOU EXTENSION 2 GRANTED |
| Thursday, August 26, 2021 | SOU EXTENSION 2 FILED |
| Thursday, August 26, 2021 | TEAS EXTENSION RECEIVED |
| Tuesday, February 23, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 19, 2021 | SOU EXTENSION 1 GRANTED |
| Friday, February 19, 2021 | SOU EXTENSION 1 FILED |
| Friday, February 19, 2021 | TEAS EXTENSION RECEIVED |
| Tuesday, September 8, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 14, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 14, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 24, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, June 5, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 3, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, May 5, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, April 28, 2020 | NEW APPLICATION ENTERED |